Answers are grounded in this paper and cite their sources.
The present analysis is based on a retrospective cross-sectional Polish study including patients who underwent allogeneic hematopoietic cell transplantation (allo-HCT) over a 3-year period (2012–2014). The aim of the study was to evaluate the impact of the updated 2019 invasive fungal disease (IFD) diagnostic criteria on treatment outcomes and to identify risk factors for mortality. The analysis included 102 patients diagnosed with IFD for whom follow-up data were available. In accordance with the 2019 EORTC/MSGERC consensus revisions, all IFD diagnoses were re-evaluated using the available clinical data. Additionally, due to the lack of therapeutic drug monitoring (TDM), patients receiving oral posaconazole suspension who presented with multiple risk factors for IFD and radiological findings on high-resolution chest computed tomography (HRCT) suggestive of fungal infection were classified as probable IFD cases, even in the presence of negative serum galactomannan (GM) results. Using the 2008 EORTC/MSG criteria, 3-month mortality rates were comparable between patients with probable and proven IFD (47.4% and 50%, respectively) and lower among patients classified as possible IFD (27.9%). In contrast, application of the modified 2019 IFD definitions resulted in a clearer stratification of patients into possible, probable, and proven IFD categories, with distinct 3-month mortality rates of 16%, 36%, and 52.4%, respectively. In multivariate analysis, neutropenia occurring at any time after transplantation – a major risk factor for IFD development – was independently associated with increased mortality. Moreover, proven IFD diagnosed according to the updated criteria significantly increased the risk of IFD-related death. In conclusion, reclassification of IFD according to updated criteria and adjustment for historical diagnostic limitations improved prognostic stratification, yielding clinically meaningful differences in mortality among possible, probable, and proven IFD cases.
No takes yet. Share an insight, caveat, or question.
Mensah‐Glanowska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: